Krystal Biotech Inc (KRYS)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -42,637 | -77,807 | -41,883 | -15,096 | -6,758 |
| Revenue | US$ in thousands | 55,764 | 498 | — | — | — |
| Gross profit margin | -76.46% | -15,623.90% | — | — | — |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-42,637K ÷ $55,764K
= -76.46%
Based on the data provided, it is evident that Krystal Biotech Inc has experienced significant fluctuations in its gross profit margin over the past five years. The gross profit margin for December 31, 2023, stood at a concerning -76.46%, indicating that the company's cost of goods sold exceeded its sales revenue by a substantial margin during that period.
Furthermore, the gross profit margin for December 31, 2022, was even more alarming at -15,623.90%, suggesting a significant loss incurred in the generation of revenue from its core business activities. Unfortunately, data for the years 2021, 2020, and 2019 is not available for comparison.
Overall, the consistently negative and sizable gross profit margins over the reported years raise serious concerns about the efficiency of Krystal Biotech's cost management and pricing strategies, as well as potential challenges in generating profitable revenues from its products or services. Further analysis of the company's cost structure and revenue streams is warranted to address these issues and improve its financial performance in the future.
Peer comparison
Dec 31, 2023